A kinetic overview of the receptors involved in 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 signaling: A systems biology approach

Critical Reviews in Eukaryotic Gene Expression

Volumn 19, Issue 3, 2009, Pages 181-196

  Holmén, Jonathan ^a   Jansson, Andreas ^a   Larsson, Dennis ^a  

^a UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

Catalase; Mathematical modeling; NVDR; PDIA3; Receptor kinetics; Vitamin D

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; CALCITRIOL; COLECALCIFEROL RECEPTOR; MUTANT PROTEIN;

BINDING KINETICS; CELL FUNCTION; COMPUTER MODEL; COMPUTER SIMULATION; ENDOCRINE SYSTEM; GENETIC MODEL; HUMAN; MATHEMATICAL MODEL; MEMBRANE BINDING; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VITAMIN METABOLISM;

24,25-DIHYDROXYVITAMIN D 3; ANIMALS; CALCITRIOL; HUMANS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; VITAMIN D; VITAMINS;

EID: 67650314922     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v19.i3.20     Document Type: Review

References (83)

1. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocrine Rev. 1995;16(2):200-57.
2. Falkenstein E, Tillmann H-C, Christ M, Feuring M, and Wehling M. Multiple actions of steroid hormones - A focus on rapid nongenomic effects. Pharmacol Rev. 2000;54(4):513-55.
3. Norman AW, Mizwicki MT, Norman DPG. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nature Rev. 2004;3:27-41.
4. Deeb KK, Trump DL, Johnson CS. Vitamin D signaling pathways in cancer: Potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684-700.
5. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689S-96S.
6. Khanal RC, Nemere I. Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr. 2007;17(1):31-47.
7. Montecino M, Stein GS, Stein JL, Lian JB, Van Wijnen AJ, Carvallo L, Marcellini S, Cruzat F, Arriagada G. Vitamin D control of gene expression: Temporal and spatial parameters for organization of the regulatory machinery. Crit Rev Eukar Gen Express. 2008;18(2):163-72.
8. 3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem. 1994;269(38):23750-6.
9. 3 from chick intestine. J Endocrinol. 2002;172:211-9.
10. 3. Mol Cell Endocrinol. 2002;197:1-13.
11. 3-MARRS)-binding protein. J Steroid Biochem Mol Biol. 2004;89-90:281-5.
12. 3-MARRS)-binding protein in rat IEC-6 cells. Steroids. 2005;70:458-63.
13. 3 binds to catalase. J Cell Biochem. 2006;97:1259-66.
14. 3. Steroids. 2007;72(2):158-64.
15. Ebert R, Schütze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol. 2006;248:149-59.
16. Christakos S, Dhawan P, Liu Y, Peng X, Porta A. New insights into the mechanisms of vitamin D action. J Cell Biochem. 2003;88:695-705.
17. Fleet JC. Rapid, membrane-initiated actions of 1,25 dihydroxyvitamin D: What are they and what do they mean. J Nutr. 2004;134(12):3215-8.
18. 3 is independent of PDIA3 (1,25-MARRS). Curr Trends Ster Res. 2008;5:17-24.
19. 3 in LNCaP cancer prostate cells. Adv Exp Med Biol. 2008;617:573.
20. 3 to annexin II: Effect of vitamin D metabolites and calcium. J Cell Biochem. 2000;80:259-65.
21. 3 is present in an intestinal caveolae membrane fraction. Biochem Biophys Res Comm. 2002;298:414-9.
22. 3 in vivo and in vitro. Mol Endocrinol. 2004;18:2660-71.
23. Mizwicki MT, Bula CM, Bishop JE, Norman AW. New insights into vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model. J Steroid Biochem Mol Biol. 2007;103:243-62.
24. Aderem A. Systems biology: Its practice and challenges. Cell. 2005;121(4):511-3.
25. Liu ET. Systems biology, integrative biology, predictive biology. Cell. 2005;121(4):505-6.
26. Materi W, Wishart DS. Computational systems biology in drug discovery and development: methods and applications. Drug Discov Today. 2007;12(7-8):295-303.
27. Kumar N, Hendriks BS, Janes KA, de Graaf D, Lauffenburger DA. Applying computational modeling to drug discovery and development. Drug Discov Today. 2006;11(17-18):806-11.
28. Hendriks BS, Cook J, Burke JM, Beusmans JM, Lauffenburger DA, de Graaf D. Computational modeling of ErbB family phosphorylation dynamics in response to transforming growth factor alpha and heregulin indicates spatial compartmentation of phosphatase activity. Syst Biol (Stevenage). 2006;153(1):22-33.
29. Lauffenburger DA, Linderman JJ. Receptors: Models for binding, traffcking, and signaling. New York: Oxford University Press, 1993.
30. Reschly EJ, Celso Dias Bainy A, Mattos JJ, Hagey LR, Bahary N, Mada SR, Ou J, Venkataramanan R, Krasowski MD. Functional evolution of the vitamin D and pregnane X receptors. BMC Evol Biol. 2007;7:222.
31. Whitfield GK, Dang HTL, Schluter SF, Bernstein RM, Bunag T, Manzon LA, Hsieh G, Dominguez CE, Youson JH, Haussler MR, Marchalonis J. Cloning of a functional vitamin D receptor from the Lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth. Endocrinology. 2003;144(6):2704-16.
32. Norman AW. Vitamin D receptor: New assignments for an already busy receptor. Endocrinology. 2006;147:5542-8.
33. Berk DA, Yuan F, Leunig M, Jain RK. Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc Natl Acad Sci USA. 1997;94:1785-90.
34. 3 and intestinal calcium transport: from receptors to physiological response. Recent Res Devel Endocrinol. 2001;2:183-98.
35. Lele T, Oh P, Nickerson JA, Ingber DE. An improved mathematical approach for determination of molecular kinetics in living cells with FRAP. MCB. 2004;1(3):181-90.
36. Ohsugi Y, Saito K, Tamura M, Kinjo M. Lateral mobility of membrane-binding proteins in living cells measured by total internal reflection fluorescence correlation spectroscopy. Biophys J. 2006;91:3456-64.
37. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishi Y, Suda T. 1α,25-dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982;204:713-9.
38. Crofts LA, Hancock MS, Morrison NA, Eisman JA. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts (1,25-dihydroxyvitamin D/gene structure). Proc Natl Acad Sci USA. 1998; 95:10529-34.
39. Bolander FF. Molecular endocrinology. San Diego (CA): Elsevier Academic Press, 2004.
40. Mohr SC, Swamy N, WenRong X, Rayu R. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1α,25- dihydroxyvitamin D3 receptor. Steroids. 2001;66:189-201.
41. 3 receptor. J Biol Chem. 1996;271(9):5143-9.
42. Larsson D. Vitamin D in teleost fish: Non-genomic regulation of intestinal calcium transport. Göteborg (Sweden): Göteborg University Press, 1999.
43. 3in basal lateral membranes of enterocytes from the freshwaterfish Carp. Am J Phys Endocrinol Metab. 2000;279:E614-21.
44. 3 in carp and atlantic cod enterocytes: Characterization of binding and effects on intracellular calcium regulation. J Cell Biochem. 2001;83:171-86.
45. 3 in osteoblasts. Steroids. 2002;67:235-46.
46. 3 - I: Calcium transport, receptor kinetics, and signal transduction in intestine of male chickens. Endocrinology. 2003;144:1726-35.
47. 3 - II: Calcium transport, receptor kinetics, and signal transduction in intestine of female chickens. J Cell Biochem. 2003;90:901-13.
48. 3, in rainbow trout. Endocrinology. 2003;144:559-66.
49. Gáborik Z, Hunyady L. Intracellular trafficking of hormone receptors. Trends Endocrinol Metab. 2004;15(6):286-93.
50. Jansson A, Harlén M, Karlsson S, Nilsson P, Cooley M. 3D computation modelling of the influence of cytokine secretion on Th-cell development suggests that negative selection (inhibition of Th1 cells) is more effective than positive selection by IL-4 for Th2 cell dominance. Immunol Cell Biol. 2007;85:189-96.
51. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70.
52. Huang CY, and Ferrell JE Jr. Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 1996;93:10078-83.
53. Bhalla US, Lyengar R. Emergent properties of networks of biological signaling pathways. Science. 1999;283:381-7.
54. Hay AW, Watson G. Binding properties of serum vitamin D transport protein in vertebrates for 24R, 25-dihydroxy cholecalciferol and 24S, 25-dihydroxycholecalciferol in vitro. Comp Biochem Physiol B. 1977;58(1):43-8.
55. Zhuang SH, Schwartz GG, Cameron D, Burnstein KL. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Mol Cell Endocrinol. 1997;126:83-90.
56. 3 metabolism limits receptor occupancy and target tissue responsiveness. J Biol Chem. 1989;264(27):15917-21.
57. Takahashi N, Abe E, Tanabe R, Suda TA. High-affinity cytosol binding protein for 1α,25-dihydroxycholecalciferol in the uterus of Japanese quail. Biochem J. 1980;190:513-8.
58. 3 in rat skin. Proc Natl Acad Sci USA. 1980;77(10):5822-6.
59. 3 binding macromolecule in chicken bone. J Biol Chem. 1980;255(9):4081-6.
60. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ. Increased intestinal vitamin D receptor in genetic hypercalciuric rats: A cause of Intestinal calcium hypera-bsorption. J Clin Invest. 1993;93:661-7.
61. 3 to its chick intestinal chromatin receptor. J Biol Chem. 1985;260(18):10087-92.
62. Berry JL, Farquharson C, Whitehead CC, Mawer EB. Growth plate chondrocyte vitamin D receptor number and affnity are reduced in avian tibial dyschondroplastic lesions. Bone. 1996;19(2):197-203.
63. Malloy PJ, Eccleshall TR, Gross C, Van Maldergem L, Bouillon R, Feldman D. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that result in decreased affnity for hormone and cellular hyporesponsiveness. J Clin Invest. 1997;99:297-304.
64. 3 with a trans-fused decalin CD-ring has pronounced genomic activity. J Biol Chem. 2003;278(37):35476-82.
65. 3: Evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus. Bone. 1998;23(2):141-6.
66. 3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus. Biochem Biophys Res Commun. 1996;225:203-8.
67. 3. 1999;14(6):856-67.
68. Whitfield GK, Hsieh JC, Nakajima S, MacDonald PN, Thompson PD, Jurutka PW, Haussler CA, Haussler MR. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol Endocrinol. 1995;9:1166-79.
69. Masuyama H, Brownfield CM, St-Arnaud R, MacDonald PN. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptoractivated transcription and coactivator interaction. Mol Endocrinol. 1997;11:1507-17.
70. Chen S, Costa CHRM, Nakamura K, Ribeiro RCJ, Gardner DG. Vitamin D-dependent suppression of human atrial natriuretic peptide gene promoter activity requires heterodimer assembly. J Biol Chem. 1999;274(16):11260-6.
71. Nakajima S, Hsieh JC, MacDonald PN, Galligan MA, Haussler CA, Whitfield GK, Haussler MR. The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affnity binding to the vitamin D-responsive element. Mol Endocrinol. 1994;8:159-72.
72. 3 receptor is functionally linked to the transactivation domain 2 (AF-2). Nucl Acid Res. 1996;24(22):4513-8.
73. Kraichely DM, Collins JJ, DeLisle RK, MacDonald PN. The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction. J Biol Chem. 1999;274(20):14352-8.
74. 3 receptor are important for the binding of calcitriol. FEBS Lett. 1998;440:203-7.
75. 3 receptor for conformation and ligand binding. Biochem Biophys Res Commun. 1999;264:478-82.
76. 3 analogs. Eur J Biochem. 1999;261:706-13.
77. Jurutka PW, Hsieh J-C, Nakajima S, Haussler CA, Whitfield GK, Haussler MR. Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation. Proc Natl Acad Sci USA. 1996;93:3519-24.
78. Chung I, Wong MK, Flynn G, Yu W-D, Johnson C S, Trump DL. Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells. Cancer Res. 2006;66(17):8565-73.
79. MacDonald PN, Haussler CA, Terpening CM, Galligan MA, Reeder MC, Whitfield GK, Haussler MR. Baculovirus-mediated expression of the human vitamin D receptor. J Biol Chem. 1991;266(28):18808-13.
80. Gross C, Musiol IM, Eccleshall TR, Malloy PJ, Feldman D. Vitamin D receptor gene polymorphisms: Analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts. Biochem Biophys Res Commun. 1998;242:467-73.
81. Malloy PJ, Hochberg Z, Pike JW, Feldman D. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. J Clin Endocrinol Metab. 1989;69:263-9.
82. Whitfield GK, Selznick SH, Haussler CA, Hsieh JC, Galligan MA, Jurutka PW, Thompson PD, Lee SM, Zerwekh JE, Haussler MR. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: Point mutations confer reduced transactivation in response to ligand and impaired interaction with the retionoid X receptor heterodimeric partner. Mol Endocrinol. 1996;10:1617-31.
83. Jurutka PW, Hsieh J-C, Remus LS, Whitfield GK, Thompson PD, Haussler CA, Blanco JCG, Ozato K, Haussler MR. Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro. J Biol Chem. 1997;272(23):14592-9.